A2 Pill - white round, 7mm
Pill with imprint A2 is White, Round and has been identified as Zolpidem Tartrate Extended Release 6.25 mg. It is supplied by Actavis.
Zolpidem is used in the treatment of Insomnia and belongs to the drug class miscellaneous anxiolytics, sedatives and hypnotics. Risk cannot be ruled out during pregnancy. Zolpidem 6.25 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
Images for A2




Zolpidem Tartrate Extended Release
- Imprint
- A2
- Strength
- 6.25 mg
- Color
- White
- Size
- 7.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Miscellaneous anxiolytics, sedatives and hypnotics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 4 - Some potential for abuse
- Labeler / Supplier
- Actavis
- Inactive Ingredients
-
lactose anhydrous,
silicon dioxide,
hypromellose 2208 (4000 mPa.s),
hypromellose 2910 (5 mPa.s),
magnesium stearate,
methacrylic acid - methyl methacrylate copolymer (1:1),
microcrystalline cellulose,
sodium bicarbonate,
sodium lauryl sulfate,
magnesium silicate,
tartaric acid,
triethyl citrate,
titanium dioxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
00228-3481 (Discontinued) | Actavis Pharma, Inc. |
68084-0889 (Discontinued) | Amerisource Health Services |
Related images for "A2"
More about zolpidem
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,054)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: miscellaneous anxiolytics, sedatives and hypnotics
- Breastfeeding
- En español
Patient resources
Other brands
Ambien, Ambien CR, Zolpimist, Intermezzo, Edluar
Professional resources
- Zolpidem monograph
- Zolpidem (FDA)
- Zolpidem Capsule (FDA)
- Zolpidem Extended Release (FDA)
- Zolpidem Sublingual (FDA)
Other brands
Ambien, Ambien CR, Zolpimist, Intermezzo, Edluar
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.